Osprey Private Wealth LLC Grows Position in Regeneron Pharmaceuticals, Inc. $REGN

Osprey Private Wealth LLC significantly increased its stake in Regeneron Pharmaceuticals, Inc. by 55.4% in the fourth quarter, now holding 5,035 shares valued at $3.89 million. Other institutional investors also adjusted their positions, and institutions collectively own 83.31% of the company’s stock. Regeneron recently surpassed quarterly earnings and revenue estimates, with analysts rating the stock as a “Moderate Buy” with a target price of $826.59.

REGN-2.09%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned